Form 4: Elanco CEO Acquires Deferred Stock Units
Insider Transaction Report
Elanco Animal Health CEO Jeffrey N. Simmons acquired 134.1686 deferred stock units, increasing his beneficial ownership to 17,970.3106 units.
Summary
- Jeffrey N. Simmons, President, CEO, and Director of Elanco Animal Health Inc (ELAN), acquired 134.1686 Deferred Stock Units (DSUs).
- The transaction date for the acquisition of these DSUs was October 3, 2025.
- Each DSU represents the right to receive one share of Company common stock or its cash equivalent.
- The price of the derivative security (DSU) was $20.64 per unit.
- Following this transaction, Jeffrey N. Simmons beneficially owns a total of 17,970.3106 derivative securities (DSUs).
- The DSUs settle in cash or shares of Company common stock upon termination of employment or during a specified future year, as per the Executive Deferral and Stock Match Plan.
Sentiment
Score: 6
Explanation: The sentiment is slightly positive due to increased insider ownership, which generally signals confidence and aligns management's interests with shareholders. However, the relatively small number of units acquired limits the overall positive impact.
Positives
- The acquisition of deferred stock units by the CEO increases his equity stake, aligning management's interests with those of shareholders.
- The transaction is part of a compensation plan, indicating ongoing executive participation in the company's equity.
Future Outlook
The acquired Deferred Stock Units are scheduled to settle in cash or shares of Company common stock following termination of employment or during a specified future year, in accordance with the Executive Deferral and Stock Match Plan.
Industry Context
This filing represents a routine insider equity transaction, common across various industries, where executive compensation includes deferred stock units to align long-term interests with company performance.
Stakeholder Impact
- Shareholders: Increased alignment of the CEO's financial interests with the company's long-term performance, potentially fostering greater confidence.
- Employees: No direct impact mentioned, but executive compensation structures can influence overall company culture and morale.
Next Steps
- The Deferred Stock Units will settle in cash or shares of common stock upon termination of employment or during a specified future year.
Key Dates
| Date | Description |
|---|---|
| 10/03/2025 | Date of earliest transaction and transaction date for the acquisition of Deferred Stock Units. |
| 10/07/2025 | Date the Form 4 was signed by Amy C. Seidel, as Attorney-in-Fact for Jeffrey N. Simmons. |
Keywords
Elanco Animal Health, ELAN, Jeffrey N Simmons, Deferred Stock Units, DSU, Insider Transaction, Executive Compensation, Equity Grant, SEC Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.